Eurand Announces Data On Switching Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency From Unapproved PEPs To FDA-Approved ZENPEP(R)
Originally posted in Cystic Fibrosis News From Medical News Today
Eurand Pharmaceuticals, Inc., a subsidiary of global specialty pharmaceutical company Eurand N.V…
No Comments
RSS feed for comments on this post.
















by Raelene














